Eli Lilly and Co

LLY

Company Profile

  • Business description

    Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

  • Contact

    Lilly Corporate Center
    IndianapolisIN46285
    USA

    T: +1 317 276-2000

    E: [email protected]

    https://www.lilly.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    47,000

Eli Lilly and Co News & Analysis

stocks

Eli Lilly earnings: Weak Orforglipron obesity data weighs down a strong quarter

With today’s share drop, we think Lilly stock looks fairly valued.
markets

June 2025 US stock market outlook: Has the storm passed?

Be wary of the recent complacency; there’s turbulent water ahead before the skies clear.
markets

US stock market outlook: Where we see opportunities in Q2

A bear market in AI stocks leads to more attractive valuations.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,321.1010.80-0.12%
CAC 408,206.8751.99-0.63%
DAX 4024,151.13178.90-0.74%
Dow JONES (US)46,602.33322.41-0.69%
FTSE 1009,533.90106.911.13%
HKSE25,781.77245.78-0.94%
NASDAQ22,725.88227.78-0.99%
Nikkei 22549,307.798.27-0.02%
NZX 50 Index13,306.4471.41-0.53%
S&P 5006,698.8236.53-0.54%
S&P/ASX 2009,030.0010.30-0.11%
SSE Composite Index3,913.762.57-0.07%

Market Movers